BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21935589)

  • 1. Development of a measles vaccine production process in MRC-5 cells grown on Cytodex1 microcarriers and in a stirred bioreactor.
    Trabelsi K; Majoul S; Rourou S; Kallel H
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):1031-40. PubMed ID: 21935589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.
    Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H
    Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
    Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U
    Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral antigen production in cell cultures on microcarriers Bovine parainfluenza 3 virus and MDBK cells.
    Conceição MM; Tonso A; Freitas CB; Pereira CA
    Vaccine; 2007 Nov; 25(45):7785-95. PubMed ID: 17920165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-l bioreactor.
    Kallel H; Rourou S; Majoul S; Loukil H
    Appl Microbiol Biotechnol; 2003 Jun; 61(5-6):441-6. PubMed ID: 12764557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor.
    Arifin MA; Mel M; Abdul Karim MI; Ideris A
    J Biomed Biotechnol; 2010; 2010():586363. PubMed ID: 20625497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
    Genzel Y; Olmer RM; Schäfer B; Reichl U
    Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scalable culture systems using different cell lines for the production of Peste des Petits ruminants vaccine.
    Silva AC; Delgado I; Sousa MF; Carrondo MJ; Alves PM
    Vaccine; 2008 Jun; 26(26):3305-11. PubMed ID: 18486286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
    Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
    J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-titer adenovirus vector production in 293S cell perfusion culture.
    Cortin V; Thibault J; Jacob D; Garnier A
    Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
    Genzel Y; Fischer M; Reichl U
    Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel process for production of hepatitis A virus in Vero cells grown on microcarriers in bioreactor.
    Sun MB; Jiang YJ; Li WD; Li PZ; Li GL; Jiang SD; Liao GY
    World J Gastroenterol; 2004 Sep; 10(17):2571-3. PubMed ID: 15300909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing efficiency of human mesenchymal stromal cell culture by optimization of microcarrier concentration and design of medium feed.
    Chen AK; Chew YK; Tan HY; Reuveny S; Weng Oh SK
    Cytotherapy; 2015 Feb; 17(2):163-73. PubMed ID: 25304664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High vero cell density and rabies virus proliferation on fibracel disks versus cytodex-1 in spinner flask.
    Hassanzadeh SM; Zavareh A; Shokrgozar MA; Ramezani A; Fayaz A
    Pak J Biol Sci; 2011 Apr; 14(7):441-8. PubMed ID: 21902056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers.
    Berry JM; Barnabé N; Coombs KM; Butler M
    Biotechnol Bioeng; 1999 Jan; 62(1):12-9. PubMed ID: 10099508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.
    Rourou S; Ben Zakkour M; Kallel H
    Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of yellow fever virus in microcarrier-based Vero cell cultures.
    Souza MC; Freire MS; Schulze EA; Gaspar LP; Castilho LR
    Vaccine; 2009 Oct; 27(46):6420-3. PubMed ID: 19559120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of human diploid cell MRC-5, for production of measles and rubella virus vaccines.
    Mirchamsy H; Shafyi A; Bahrami S; Kamali M; Nazari P
    Dev Biol Stand; 1976 Dec 13-15; 37():297-300. PubMed ID: 1031692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-cell-density cultivations to increase MVA virus production.
    Vázquez-Ramírez D; Genzel Y; Jordan I; Sandig V; Reichl U
    Vaccine; 2018 May; 36(22):3124-3133. PubMed ID: 29433897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.